Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1999
12/09/1999WO1999062885A1 Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
12/09/1999WO1999062884A1 Pyrazoline derivatives, their preparation and application as medicaments
12/09/1999WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999WO1999062872A1 New 3-aryl-2-hydroxypropionic acid derivative (i)
12/09/1999WO1999062561A2 Gene therapy method
12/09/1999WO1999062560A1 Stabilization of compositions containing ace inhibitors using magnesium oxide
12/09/1999WO1999062551A1 Texaphyrin conjugates and uses thereof
12/09/1999WO1999062545A2 GnRH VACCINES FOR SUPPRESSING REPRODUCTIVE BEHAVIOUR IN ANIMALS
12/09/1999WO1999062543A1 Composition based on pentoxifylline and anticytokin
12/09/1999WO1999062539A1 Lysine containing peptides for treatment of heart disease
12/09/1999WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999WO1999062536A2 Pharmaceutical formulations for igf/igfbp
12/09/1999WO1999062531A1 Monoamine oxidase (mao) inhibitors and uses thereof
12/09/1999WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999WO1999062524A1 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
12/09/1999WO1999062523A1 Bridged indenopyrrolocarbazoles
12/09/1999WO1999062517A1 METHOD OF ENHANCING LYSOSOMAL α-GALACTOSIDASE A
12/09/1999WO1999062516A1 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer
12/09/1999WO1999062511A1 Neurotrophic difluoroamide agents
12/09/1999WO1999062509A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension
12/09/1999WO1999062507A1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
12/09/1999WO1999062506A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/09/1999WO1999062503A2 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
12/09/1999WO1999062498A1 Spill resistant pharmaceutical compositions
12/09/1999WO1999062491A1 Small molecule pipecolic acid derivative hair growth compositions and uses
12/09/1999WO1999062490A1 Small molecule sulfonamide hair growth compositions and uses
12/09/1999WO1999062489A1 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses
12/09/1999WO1999062488A1 Heterocyclic thioester and ketone hair growth compositions and uses
12/09/1999WO1999062486A1 N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
12/09/1999WO1999062485A1 N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
12/09/1999WO1999062484A1 Small molecule carbamate or urea hair growth compositions and uses
12/09/1999WO1999062483A1 Pipecolic acid derivative hair growth compositions and uses
12/09/1999WO1999054445A3 Combination therapy using nucleic acids and conventional drugs
12/09/1999WO1999052938A3 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
12/09/1999WO1999051262A3 Use of igfi for treating articular cartilage disorders
12/09/1999WO1999051260A3 Treatment of cardiac hypertrophy
12/09/1999WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions
12/09/1999WO1999046367A3 Methods of diagnosis and triage using cell activation measures
12/09/1999WO1999043285A3 Sulphonamide derivatives
12/09/1999WO1999026583A3 Inhibtion of lipoprotein oxidation
12/09/1999WO1999006397A3 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
12/09/1999DE19825494A1 Neuer Angiotensin Rezeptor, Herstellung und Verwendung desselben The same new angiotensin receptor preparation and use
12/09/1999CA2334809A1 Texaphyrin conjugates and uses thereof
12/09/1999CA2334396A1 Heterocyclic thioester and ketone hair growth compositions and uses
12/09/1999CA2334395A1 Small molecule sulfonamide hair growth compositions and uses
12/09/1999CA2334258A1 Potassium channel inhibitors
12/09/1999CA2334186A1 Monoamine oxidase (mao) inhibitors and uses thereof
12/09/1999CA2334171A1 Gene therapy method
12/09/1999CA2334032A1 N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
12/09/1999CA2334008A1 N-linked sulfonamide of heterocyclic thioester hair growth compounds and uses
12/09/1999CA2333997A1 Neurotrophic difluoroamide agents
12/09/1999CA2333961A1 Small molecule pipecolic acid derivative hair growth compositions and uses
12/09/1999CA2333776A1 Composition based on pentoxifylline and anticytokin
12/09/1999CA2333771A1 Hiv integrase inhibitors
12/09/1999CA2333752A1 Aminosugar, glycosaminoglycan, and s-adenosylmethionine composition for the treatment and repair of connective tissue
12/09/1999CA2333698A1 Pipecolic acid derivative hair growth compositions and uses
12/09/1999CA2333693A1 N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
12/09/1999CA2333689A1 New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing said compounds
12/09/1999CA2333679A1 Small molecule carbamate or urea hair growth compositions and uses
12/09/1999CA2333661A1 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases
12/09/1999CA2332957A1 Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
12/09/1999CA2331791A1 Aromatic amine derivatives as pharmaceutical agents
12/09/1999CA2330581A1 Stabilization of compositions containing ace inhibitors using magnesium oxide
12/09/1999CA2330567A1 Lysine containing peptides for treatment of heart disease
12/09/1999CA2330191A1 Protease inhibitor peptides
12/09/1999CA2330179A1 Human homologue of unc-53 protein of c. elegans
12/09/1999CA2329940A1 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999CA2329435A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension
12/09/1999CA2329132A1 Method of designing agonists and antagonists to egf receptor family
12/08/1999EP0962552A1 A process for the preparation of 4-(des-dimethylamino)-tetracyclines
12/08/1999EP0962457A1 Piperidones as tachykinin antagonists
12/08/1999EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999EP0961618A1 Novel compounds
12/08/1999EP0961613A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
12/08/1999EP0923557A4 Stereoselective deoxygenation reaction
12/08/1999EP0824545B1 Peptide compositions with growth factor-like activity
12/08/1999EP0771196B1 Excitatory amino acid receptor antagonists
12/08/1999EP0730587B1 3-phenyl-2-isoxazolines as antiinflammatory agents
12/08/1999EP0712387B1 2-aminoindans as selective dopamine d3 ligands
12/08/1999EP0678086B1 Compounds having selectivity for retinoid x receptors
12/08/1999EP0664780B1 10-substituted 1,8-dihydroxy-9(10h) anthracenone pharmaceuticals
12/08/1999EP0643716B1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/08/1999CN1238010A Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
12/08/1999CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use
12/08/1999CN1237978A N (aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and method for inhibiting 'beta'-amyloid peptide release and/or its synthesis by use of such compounds
12/08/1999CN1237969A Multivalent salts of pyridostigmine and related compounds
12/08/1999CN1237962A Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
12/08/1999CN1237906A New use for 1,3-propanediol derivatives
12/08/1999CN1047075C Bisacodyl dosage form
12/07/1999US5998630 A 1-(3-(1-pyrrolidinyl)propy)-3-ethylcarbodiimide
12/07/1999US5998622 Analgesics; antiinflammatory agents; side effect reduction
12/07/1999US5998586 Interleukin-5 specific recombinant antibodies
12/07/1999US5998584 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/07/1999US5998583 BH3 interacting domain death agonist
12/07/1999US5998579 Epimorphin antagonist and process for producing it
12/07/1999US5998578 Biologically active fragments of IL-1β
12/07/1999US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
12/07/1999US5998474 Reduction of oxygen free radicals; nervous system disorders,cardiovascular disorders
12/07/1999US5998470 Osteoporosis; oral diseases; antiarthritic agents
1 ... 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 ... 1564